Costa Rica vs Eastern Mediterranean (WHO region): Hypertension treatment coverage among adults aged 30-79 with
Costa Rica
70.2%
in 2019
Eastern Mediterranean (WHO region)
38.7%
in 2019
Costa Rica rank
5th
Eastern Mediterranean (WHO region) rank
6th
Hypertension treatment coverage among adults aged 30-79 with over time
- Costa Rica
- Eastern Mediterranean (WHO region)
How they compare
Costa Rica currently reports 70.2% against 38.7% in Eastern Mediterranean (WHO region), a difference of 31.5%.
That makes Costa Rica's figure about 1.8 times Eastern Mediterranean (WHO region)'s.
Across all 30 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 5th and Eastern Mediterranean (WHO region) ranks 6th of 193 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.8% | 22.7% | 14.1% | Costa Rica |
| 2000s | 49.9% | 30.9% | 19.0% | Costa Rica |
| 2010s | 65.3% | 37.5% | 27.7% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Costa Rica or Eastern Mediterranean (WHO region)?
- Costa Rica, at 70.2% against 38.7% in Eastern Mediterranean (WHO region) as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Costa Rica and Eastern Mediterranean (WHO region)?
- 31.5%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Eastern Mediterranean (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Eastern Mediterranean (WHO region) rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Costa Rica ranks 5th and Eastern Mediterranean (WHO region) ranks 6th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.